Key Metrics of Redhill Biopharma Ltd.
Revenue$64.4M▲ 0.0% YoYFY 2020
Operating income−$63.7M▲ 0.0% YoY
Net profit−$76.2M▲ 0.0% YoY
Shareholders' equity$13.9M
Market cap$3.7MRDHL · $0.42
Competitors10identified
About Redhill Biopharma Ltd.
Sectors
Company details
- Listed
- Nasdaq: RDHL
Operational Areas of Redhill Biopharma Ltd.
Pharmaceuticals & Healthcare›Biotechnology & Vaccines
Company summary
Legal nameRedhill Biopharma Ltd.
TickerRDHL
ExchangeNasdaq
CountryIsrael
SEC CIK0001553846
Listed since—
IndustryBiotechnology: Pharmaceutical Preparations
SectorPharmaceuticals & Healthcare · Biotechnology & Vaccines
Website—
US market & SEC filings
RDHL · Nasdaq · SEC CIK 0001553846
Last price · 04 Nov 2026
$0.42
−5.82%
Market cap$3.7M
P/E—On FY 2020 diluted EPS
Volume24,436
SectorHealth CareBiotechnology: Pharmaceutical Preparations
Country · IPOIsrael
RDHL share price
Premium
Annual results (SEC EDGAR)
Revenue, operating income, net income, EPS, cash flow, assets, liabilities, equity and debt for every year filed with the SEC are part of the premium plan.
Sign in to continue See plans & pricingVendor checks & payment capacity
Sign in with access to company financials to review vendor evidence.
Registered office and contact
Registered office—
GSTIN—
Email—
Website—
Members / shareholders—
Directors and key people
Directors are read from the MGT-7 annual return and AOC-4 signatories.
Competitors of Redhill Biopharma Ltd.
Competitors10identified
Countries2most in United States
Top competitors by location
| Company | Description | Domain | Founded | Location |
|---|---|---|---|---|
| Part of Vertex Pharmaceuticals. | vrtx.com | 1991 | United States | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | gsk.com | 2022 | United Kingdom | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | modernatx.com | 2018 | United States | |
 Becton Dickinson |
Biotechnology & Vaccines · Pharmaceuticals & Healthcare | bd.com | — | United States |
| Part of Illumina. | illumina.com | 2000 | United States | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | guardanthealth.com | 2018 | United States | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | revvity.com | — | United States | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | exelixis.com | 2000 | United States | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | neurocrine.com | 1996 | United States | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | biomarin.com | 1999 | United States |
Similar companies
E
Elanco Animal Health IncorporatedPharmaceuticals & Healthcare
Same segment: Biotechnology & Vaccines
M
Medtronic plc.Pharmaceuticals & Healthcare
Same segment: Biotechnology & Vaccines
S
Summit Therapeutics Inc.Pharmaceuticals & Healthcare
Same segment: Biotechnology & Vaccines
I
ICON plc (ICLR)Pharmaceuticals & Healthcare
Same segment: Biotechnology & Vaccines
C
Charles River Laboratories International Inc.Pharmaceuticals & Healthcare
Same segment: Biotechnology & Vaccines
A
Ascendis Pharma A/S Ordinary SharePharmaceuticals & Healthcare
Same segment: Biotechnology & Vaccines
M
Medpace Holdings Inc.Pharmaceuticals & Healthcare
Same segment: Biotechnology & Vaccines
I
Insmed IncorporatedPharmaceuticals & Healthcare
Same segment: Biotechnology & Vaccines
Charges (secured borrowings)
0 registered charges. Lenders, amounts and dates are part of the premium plan.
Statutory auditors
Auditors are read from the AOC-4 auditor's report section.
Business activities and related parties
Principal business activities and related-party transactions are read from MGT-7 and AOC-4 filings.
Filings
No filings on record yet.